Tirzepatide is a novel medication that acts as a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist for patients with type 2 diabetes. This dual action enhances insulin secretion, regulates blood sugar levels, and offers a comprehensive approach to diabetes management. For the latest and most credible information on Tirzepatide, join the reputed Consultant Endocrinologist, Dr. Ihab El Tayeb , in our exclusive Global Diabetes Summit session on 15 th November 2023, 3:00 PM IST onwards.
Stay Tuned for the Session! Suggested for you A Network Meta-analysis to Establish the Efficacy of SGLT-2i and GLP-1 receptor agonists Among Patients with T2DM Fluid Thickener: A New Way to Lower Postprandial Blood Glucose Levels ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to…
